DENVER HEALTH MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $56M
- Transactions
- 2,012
- Companies
- 40
- Average per transaction
- $27,810
Who reported the payments
| Purdue Pharma L.p. | $13,226,901 |
| Indivior Inc. | $5,233,531 |
| Exelixis Inc. | $5,033,653 |
| Janssen Scientific Affairs, LLC | $4,695,180 |
| Hikma Pharmaceuticals USA | $3,204,363 |
| Collegium Pharmaceutical, Inc. | $2,830,256 |
| Genentech, Inc. | $2,803,059 |
| Apellis Pharmaceuticals, Inc. | $2,416,066 |
| Mallinckrodt LLC | $2,194,257 |
| Global Blood Therapeutics, Inc. | $2,034,073 |
| BTG International Inc. | $1,725,763 |
| Dr.reddy's Laboratories,inc. | $1,351,464 |
| Upjohn US 1 LLC | $1,176,475 |
| Rhodes Pharmaceuticals L.p. | $849,644 |
| Pfizer | $838,808 |
| Gilead | $620,111 |
| Mylan Inc. | $560,233 |
| Amneal Pharmaceuticals LLC | $539,469 |
| Roche Products Limited | $536,328 |
| Syndax Pharmaceuticals, Inc. | $386,791 |
| Dompe Farmaceutici S.p.a. | $363,279 |
| Prytime Medical Devices, Inc. | $322,382 |
| Teva Pharmaceuticals USA, Inc. | $303,433 |
| Janssen Research & Development, LLC | $297,360 |
| Sanofi Pasteur Inc. | $263,695 |
| Medical Device Business Services, Inc. | $250,950 |
| Gen-probe, Inc. | $243,653 |
| Haemonetics Corporation | $123,385 |
| Merck | $116,824 |
| Amgen | $115,893 |
| Mylan Specialty L.p. | $109,519 |
| Mimedx Group, Inc. | $105,000 |
| Baxter Healthcare | $102,186 |
| Zimmer Biomet | $72,546 |
| Angiodynamics, Inc. | $64,039 |
| Hemosonics LLC | $62,562 |
| Diagnostica Stago, Inc | $60,489 |
| UCB SA | $59,421 |
| Humacyte Global, Inc. | $58,670 |
| Siemens Medical Solutions USA, Inc. | $42,828 |